| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 25/08/2021 | 19:00 | Business Wire | theScore Bet Becomes Official Gaming Partner of Golf Canada and its Marquee Golf Championships, the RBC Canadian Open and CP Women’s Open | NASDAQ:SCRX | Sciele Pharma (MM) |
| 19/08/2021 | 16:00 | Business Wire | theScore Selects Toronto’s Waterfront Innovation Centre as Site for New, Expansive Headquarters | NASDAQ:SCRX | Sciele Pharma (MM) |
| 05/08/2021 | 13:01 | Business Wire | Penn National Gaming to Acquire Score Media and Gaming, Creating North America’s Leading Digital Sports Content, Gaming and Technology Company | NASDAQ:SCRX | Sciele Pharma (MM) |
| 13/07/2021 | 23:01 | Business Wire | theScore Reports F2021 Q3 Financial Results | NASDAQ:SCRX | Sciele Pharma (MM) |
| 06/07/2021 | 13:30 | Business Wire | theScore to Report Q3 F2021 Financial Results on Tuesday, July 13, 2021 | NASDAQ:SCRX | Sciele Pharma (MM) |
| 22/06/2021 | 22:16 | Business Wire | theScore Applauds Passage by the Senate of Historic Legislation to Legalize Single Event Sports Betting in Canada | NASDAQ:SCRX | Sciele Pharma (MM) |
| 23/04/2021 | 01:41 | Business Wire | theScore Issues Statement Following the Passing of Bill C-218 by the House of Commons | NASDAQ:SCRX | Sciele Pharma (MM) |
| 13/04/2021 | 23:02 | Business Wire | theScore Reports Record F2021 Q2 Financial Results | NASDAQ:SCRX | Sciele Pharma (MM) |
| 06/04/2021 | 13:45 | Business Wire | theScore To Report Q2 F2021 Financial Results on Tuesday, April 13, 2021 | NASDAQ:SCRX | Sciele Pharma (MM) |
| 30/03/2021 | 19:02 | Business Wire | PGA TOUR Announces theScore Bet as an Official Betting Operator | NASDAQ:SCRX | Sciele Pharma (MM) |
| 29/03/2021 | 14:30 | Business Wire | theScore Secures Market Access for Mobile Sports Betting in Illinois Through Agreement with Caesars Entertainment | NASDAQ:SCRX | Sciele Pharma (MM) |
| 01/03/2021 | 17:04 | Business Wire | theScore Announces Closing of US$186.3 Million Initial Public Offering in the United States | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/10/2008 | 23:01 | Business Wire | Shionogi Completes Acquisition of Sciele | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/10/2008 | 17:10 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/10/2008 | 14:02 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/10/2008 | 13:30 | Business Wire | Shionogi and Sciele Announce Completion of Subsequent Offering Period | NASDAQ:SCRX | Sciele Pharma (MM) |
| 06/10/2008 | 15:54 | Edgar (US Regulatory) | Sciele Pharma, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 06/10/2008 | 12:30 | Business Wire | Shionogi and Sciele Announce Successful Tender Offer and Commencement of Subsequent Offering | NASDAQ:SCRX | Sciele Pharma (MM) |
| 06/10/2008 | 12:05 | Edgar (US Regulatory) | Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 26/09/2008 | 01:38 | PR Newswire (US) | Standard & Poor's Announces Update to the U.S. Market Cap Guidelines and Changes to U.S. Indices | NASDAQ:SCRX | Sciele Pharma (MM) |
| 19/09/2008 | 12:00 | Business Wire | Shionogi and Sciele Announce Receipt of United States Antitrust Clearance | NASDAQ:SCRX | Sciele Pharma (MM) |
| 16/09/2008 | 15:46 | Business Wire | Sciele Completes Pivotal Phase III Program for Glycopyrrolate in Pediatric Patients with Chronic, Moderate-to-Severe Drooling | NASDAQ:SCRX | Sciele Pharma (MM) |
| 08/09/2008 | 17:19 | Edgar (US Regulatory) | Sciele Pharma, Inc. - Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 08/09/2008 | 17:03 | Edgar (US Regulatory) | Sciele Pharma, Inc. - Tender offer statement by Third Party (SC TO-T) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 03/09/2008 | 22:49 | Edgar (US Regulatory) | Sciele Pharma, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 03/09/2008 | 22:47 | Edgar (US Regulatory) | Sciele Pharma, Inc. - Current report filing (8-K) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 02/09/2008 | 20:14 | Edgar (US Regulatory) | Sciele Pharma, Inc. - Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 02/09/2008 | 17:44 | Marketwired | BellwetherReport.com Analyst Opinions on SCRX, AGIX, BUCY and ISIL | NASDAQ:SCRX | Sciele Pharma (MM) |
| 01/09/2008 | 11:01 | Business Wire | Shionogi & Co., Ltd. to Acquire Sciele Pharma, Inc. | NASDAQ:SCRX | Sciele Pharma (MM) |
| 27/08/2008 | 16:10 | Edgar (US Regulatory) | Sciele Pharma, Inc. - Initial Statement of Beneficial Ownership (3) | NASDAQ:SCRX | Sciele Pharma (MM) |